Eppendorf
  Editorial
 AMENDMENT OF SCHEDULE K   
 Wednesday, April 7, 2021 
 Recently, the Union Health Ministry has issued a Gazette notification amending some of the provisions in Schedule K of Drugs and Cosmetics Act to empower lakhs of Anganwadi workers and community health officers at Ayushman Bharat health and wellness centres across the nook 
  Past Editorial...  
MSC
TODAY'S NEWS
18:00  [IST]Antengene begins patient dosing in phase II trial of ATG-008 to treat advanced solid tumors with specific genetic alterations
17:00  [IST]ImmunOs Therapeutics gets public funding from Eurostars and Innosuisse for novel therapeutic antibody to treat inflammatory rheumatic diseases
16:00  [IST]Abcam, MEDx extend partnership to include co-develop & commercialize key companion and in vitro diagnostic kits in Chinese market
15:30  [IST]Oncolytics Biotech, SOLTI’s AWARE-1 breast cancer study of pelareorep plus checkpoint blockade therapy meets primary endpoint
15:00  [IST]US FDA accepts Airway Therapeutics’ IND application to develop AT-100 to treat Covid-19
14:40  [IST]FICCI recommends need for PLI type scheme to ramp-up Covid-19 vaccine manufacturing in India
more news >>
TOP NEWS
08:00  [IST]DCGI again sounds alert to SLAs to take stringent action on black marketing of Covid-19 drug remdesivir
08:00  [IST]AIOCD asks all its members not to indulge in hoarding of remdesivir under any circumstances
08:00  [IST]SK Pharmacy seeks India’s support for developing pharma industry in Republic of Kazakhstan
08:00  [IST]No routine monthly EC meeting held in Tripura SPC for last one year
08:00  [IST]Sri Adichunchanagiri College in advanced stage of research to develop poly herbal formulation of nano gel
08:00  [IST]IPC releases draft chapter on "Approach to alternative rapid microbiological methods”
more news >>
Pioma_Vegoil_tea
YESTERDAY'S NEWS
18:00  [IST]RedHill Biopharma gets DSMB recommendation to continue phase 2/3 Covid-19 study of opaganib
17:00  [IST]NIH experts call for accelerated research to address concurrent HIV & Covid-19 pandemics
16:20  [IST]MediBuddy raises awareness about polycystic ovarian syndrome with digital campaign
16:10  [IST]Frost & Sullivan reveals how virtual care will impact the trillion-dollar global healthcare market
12:30  [IST]‘Tika Utsav’ is beginning of second major war against corona: PM
12:20  [IST]Natco Pharma’s partner Alvogen gets US FDA tentative approval for generic Imbruvica
more news >>
INTERVIEW  
Indian pharma garners global recognition with its capability in Covid-19 vaccine
Dr. R. Ananthanarayanan, MD & CEO, Strides Pharma Science
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the IMA’s attitude of taking cudgels against Patanjali’s Coronil as a preventive and curative ayurveda medicine for Covid-19 justified?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
truking"
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |